Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study.
about
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ RegimenImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesCUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells.Ingramon, a Peptide Inhibitor of MCP-1 Chemokine, Reduces Migration of Blood Monocytes Stimulated by Glioma-Conditioned Medium.Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients.
P2860
Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Circulating T regulatory cells ...... a patients: an in vitro study.
@en
Circulating T regulatory cells ...... a patients: an in vitro study.
@nl
type
label
Circulating T regulatory cells ...... a patients: an in vitro study.
@en
Circulating T regulatory cells ...... a patients: an in vitro study.
@nl
prefLabel
Circulating T regulatory cells ...... a patients: an in vitro study.
@en
Circulating T regulatory cells ...... a patients: an in vitro study.
@nl
P2093
P2860
P50
P1476
Circulating T regulatory cells ...... a patients: an in vitro study.
@en
P2093
Adele Mossa
Alessandra Canazza
Ambra Rizzo
Andrea Salmaggi
Elena Corsini
Laura Fariselli
P2860
P2888
P304
P356
10.1007/S11060-013-1236-X
P577
2013-09-05T00:00:00Z